LINC01189 and gastric cancer: The results showed that overexpression of LINC01189 decreased the metastatic capacity of VAX2-enhanced GC cells (Fig. 4A, C1, D1), whereas LINC01189 knockdown partially reversed the mobility potential of VAX2-reduced GC cells (Fig. 4B, C2, D2).